GERM Holdings — ETFMG Treatments Testing and Advancements ETF
All 64 reported holdings of ETFMG Treatments Testing and Advancements ETF (GERM) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Mount Vernon Liquid Assets Portfolio, LLC | 29.95% | $3.83M |
| Moderna Inc | 6.83% | $872.47K |
| Alnylam Pharmaceuticals Inc | 6.07% | $775.59K |
| BioNTech SE | 5.61% | $716.51K |
| Laboratory Corp of America Hol | 5.59% | $714.37K |
| Quest Diagnostics Inc | 5.36% | $684.85K |
| ImmunityBio Inc | 4.85% | $619.94K |
| Immunocore Holdings PLC | 4.61% | $588.85K |
| Vaxcyte Inc | 4.31% | $551.26K |
| QuidelOrtho Corp | 3.81% | $487.30K |
| Bio-Rad Laboratories Inc | 3.76% | $481.11K |
| Dynavax Technologies Corp | 3.58% | $458.17K |
| Zai Lab Ltd | 3.56% | $455.13K |
| AbCellera Biologics Inc | 3.29% | $420.09K |
| Vir Biotechnology Inc | 2.68% | $343.12K |
| BioCryst Pharmaceuticals Inc | 2.43% | $311.05K |
| OPKO Health Inc | 2.32% | $295.96K |
| CureVac NV | 1.87% | $239.02K |
| Fulgent Genetics Inc | 1.70% | $217.20K |
| Arcturus Therapeutics Holdings | 1.67% | $213.62K |
| Icosavax Inc | 1.57% | $200.15K |
| HilleVax Inc | 1.54% | $197.11K |
| Adaptive Biotechnologies Corp | 1.41% | $179.86K |
| AN2 Therapeutics Inc | 1.21% | $154.52K |
| Altimmune Inc | 1.20% | $153.26K |
| OraSure Technologies Inc | 1.20% | $152.77K |
| Novavax Inc | 1.13% | $144.57K |
| Invivyd Inc | 0.86% | $110.00K |
| Arbutus Biopharma Corp | 0.83% | $106.30K |
| SIGA Technologies Inc | 0.79% | $100.94K |
| AbbVie Inc | 0.74% | $95.15K |
| First American Government Obli | 0.74% | $94.80K |
| Regeneron Pharmaceuticals Inc | 0.73% | $93.10K |
| Merck & Co Inc | 0.73% | $92.99K |
| Sanofi SA | 0.73% | $92.95K |
| Gilead Sciences Inc | 0.72% | $92.43K |
| Abbott Laboratories | 0.72% | $92.24K |
| AstraZeneca PLC | 0.71% | $91.12K |
| Gsk PLC | 0.70% | $89.98K |
| Johnson & Johnson | 0.69% | $88.56K |
| Takeda Pharmaceutical Co Ltd | 0.69% | $88.13K |
| Hologic Inc | 0.69% | $87.60K |
| Eli Lilly & Co | 0.67% | $86.27K |
| Pfizer Inc | 0.65% | $82.57K |
| Atea Pharmaceuticals Inc | 0.50% | $64.52K |
| Renovaro Biosciences Inc | 0.42% | $53.61K |
| CorMedix Inc | 0.41% | $52.25K |
| Enanta Pharmaceuticals Inc | 0.39% | $50.24K |
| Gritstone bio Inc | 0.39% | $49.31K |
| Ocugen Inc | 0.29% | $37.39K |
| Inovio Pharmaceuticals Inc | 0.28% | $35.30K |
| CEL-SCI Corp | 0.27% | $34.47K |
| Emergent BioSolutions Inc | 0.25% | $31.52K |
| XBiotech Inc | 0.24% | $30.87K |
| Cue Biopharma Inc | 0.24% | $30.20K |
| Vaxxinity Inc | 0.21% | $27.32K |
| InflaRx NV | 0.19% | $24.33K |
| Vaxart Inc | 0.17% | $22.08K |
| Chimerix Inc | 0.17% | $21.69K |
| Enzo Biochem Inc | 0.14% | $17.79K |
| Cue Health Inc | 0.05% | $6.37K |
| Gurnet Point Capital LLC | 0.01% | $1.32K |
| ETFMG Sit Ultra Short ETF | 0.00% | $0 |
| Scilex Holding Co | 0.00% | $1 |
GERM overview: performance, fees, allocation and SEC filings